Biomarkers Differentiating Plaque Erosion from Stable Plaque

Area of Science:

• Cardiovascular Medicine
• Pathophysiology
• Biomarker Discovery

Background:

• Plaque erosion is a significant cause of acute coronary syndrome (ACS).
• The underlying biological mechanisms and reliable biomarkers for plaque erosion are not fully understood.
• Current knowledge gaps hinder the development of effective diagnostic and therapeutic strategies.

Purpose of the Study:

• To review the current understanding of plaque erosion.
• To identify potential biomarkers associated with plaque erosion.
• To explore the pathophysiological differences between plaque erosion and other ACS causes.

Main Methods:

• Literature review of recent studies on plaque erosion.
• Analysis of pathophysiological characteristics, including inflammatory responses and immune cell infiltration.
• Examination of molecular expression patterns in culprit lesions and thrombi.

Main Results:

• Plaque erosion exhibits distinct inflammatory profiles and immune cell infiltration patterns.
• Unique molecular expression differences are observed in erosion-related lesions.
• These findings suggest specific underlying mechanisms driving plaque erosion.
• Potential biomarkers have been identified that may aid in early detection.

Conclusions:

• Understanding the specific immune cell roles and biomarkers in plaque erosion is critical for targeted therapy development.
• Biomarker identification can facilitate early detection and treatment of erosion-prone plaques.
• This could potentially reduce the incidence of acute coronary events.